Belite Bio (BLTE) Competitors $66.80 -2.68 (-3.86%) Closing price 04:00 PM EasternExtended Trading$67.05 +0.25 (+0.37%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock BLTE vs. RVMD, GRFS, RYTM, LEGN, ABVX, RNA, CYTK, AXSM, NUVL, and TGTXShould you be buying Belite Bio stock or one of its competitors? The main competitors of Belite Bio include Revolution Medicines (RVMD), Grifols (GRFS), Rhythm Pharmaceuticals (RYTM), Legend Biotech (LEGN), Abivax (ABVX), Avidity Biosciences (RNA), Cytokinetics (CYTK), Axsome Therapeutics (AXSM), Nuvalent (NUVL), and TG Therapeutics (TGTX). These companies are all part of the "pharmaceutical products" industry. Belite Bio vs. Its Competitors Revolution Medicines Grifols Rhythm Pharmaceuticals Legend Biotech Abivax Avidity Biosciences Cytokinetics Axsome Therapeutics Nuvalent TG Therapeutics Belite Bio (NASDAQ:BLTE) and Revolution Medicines (NASDAQ:RVMD) are both mid-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, profitability, analyst recommendations, media sentiment, valuation, earnings, risk and dividends. Does the media refer more to BLTE or RVMD? In the previous week, Revolution Medicines had 37 more articles in the media than Belite Bio. MarketBeat recorded 45 mentions for Revolution Medicines and 8 mentions for Belite Bio. Belite Bio's average media sentiment score of 0.68 beat Revolution Medicines' score of 0.46 indicating that Belite Bio is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Belite Bio 1 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Revolution Medicines 13 Very Positive mention(s) 5 Positive mention(s) 8 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral Do institutionals and insiders believe in BLTE or RVMD? 0.5% of Belite Bio shares are held by institutional investors. Comparatively, 94.3% of Revolution Medicines shares are held by institutional investors. 13.3% of Belite Bio shares are held by company insiders. Comparatively, 8.2% of Revolution Medicines shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Which has more risk & volatility, BLTE or RVMD? Belite Bio has a beta of -1.5, meaning that its share price is 250% less volatile than the S&P 500. Comparatively, Revolution Medicines has a beta of 1.12, meaning that its share price is 12% more volatile than the S&P 500. Do analysts rate BLTE or RVMD? Belite Bio currently has a consensus price target of $96.00, indicating a potential upside of 43.71%. Revolution Medicines has a consensus price target of $73.67, indicating a potential upside of 59.35%. Given Revolution Medicines' stronger consensus rating and higher possible upside, analysts plainly believe Revolution Medicines is more favorable than Belite Bio.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Belite Bio 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 3.00Revolution Medicines 0 Sell rating(s) 0 Hold rating(s) 14 Buy rating(s) 1 Strong Buy rating(s) 3.07 Which has better valuation & earnings, BLTE or RVMD? Belite Bio has higher earnings, but lower revenue than Revolution Medicines. Belite Bio is trading at a lower price-to-earnings ratio than Revolution Medicines, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBelite BioN/AN/A-$36.14M-$1.55-43.10Revolution Medicines$11.58M746.27-$600.09M-$4.50-10.27 Is BLTE or RVMD more profitable? Belite Bio's return on equity of -34.90% beat Revolution Medicines' return on equity.Company Net Margins Return on Equity Return on Assets Belite BioN/A -34.90% -33.56% Revolution Medicines N/A -41.78%-35.63% SummaryRevolution Medicines beats Belite Bio on 9 of the 15 factors compared between the two stocks. Get Belite Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for BLTE and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BLTE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BLTE vs. The Competition Export to ExcelMetricBelite BioMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.13B$3.11B$5.75B$10.28BDividend YieldN/A2.32%5.72%4.60%P/E Ratio-43.1021.3674.9926.41Price / SalesN/A240.89456.1088.49Price / CashN/A44.4425.8129.91Price / Book14.159.6413.256.28Net Income-$36.14M-$53.20M$3.29B$270.38M7 Day Performance-1.05%0.41%0.46%2.69%1 Month Performance0.26%4.23%4.59%5.98%1 Year Performance36.83%9.41%73.41%25.93% Belite Bio Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BLTEBelite Bio2.5809 of 5 stars$66.80-3.9%$96.00+43.7%+42.3%$2.13BN/A-43.1010News CoverageAnalyst ForecastHigh Trading VolumeRVMDRevolution Medicines4.1949 of 5 stars$41.06+1.4%$72.00+75.4%+6.5%$7.57B$11.58M-9.12250Analyst ForecastAnalyst RevisionGRFSGrifols4.0232 of 5 stars$10.11-0.2%$10.30+1.9%+6.7%$6.96B$7.81B8.6423,822Positive NewsRYTMRhythm Pharmaceuticals3.2989 of 5 stars$99.77-2.3%$101.57+1.8%+93.9%$6.78B$130.13M-33.15140Positive NewsLEGNLegend Biotech3.2003 of 5 stars$34.62-4.0%$74.22+114.4%-34.2%$6.66B$627.24M-39.342,609Positive NewsABVXAbivax2.3728 of 5 stars$90.00+2.2%$92.33+2.6%+616.8%$6.65BN/A0.0061News CoverageEarnings ReportAnalyst ForecastShort Interest ↑Gap DownRNAAvidity Biosciences2.1095 of 5 stars$48.05-4.6%$67.00+39.4%+7.3%$6.48B$10.73M-13.50190Analyst ForecastCYTKCytokinetics4.3878 of 5 stars$52.09-1.7%$75.38+44.7%-8.5%$6.34B$18.47M-10.21250Positive NewsAXSMAxsome Therapeutics4.9101 of 5 stars$129.29+3.3%$177.86+37.6%+26.4%$6.25B$385.69M-25.50380Positive NewsNUVLNuvalent3.1605 of 5 stars$79.83-1.3%$120.91+51.5%-8.0%$5.83BN/A-16.2940Positive NewsInsider TradeTGTXTG Therapeutics4.3105 of 5 stars$32.38+0.5%$46.25+42.8%+35.5%$5.11B$329M87.51290Insider Trade Related Companies and Tools Related Companies RVMD Alternatives GRFS Alternatives RYTM Alternatives LEGN Alternatives ABVX Alternatives RNA Alternatives CYTK Alternatives AXSM Alternatives NUVL Alternatives TGTX Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BLTE) was last updated on 9/15/2025 by MarketBeat.com Staff From Our PartnersHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredCrypto Gets Official Government Backing—Here's the WinnerTrump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Belite Bio, Inc. Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Belite Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BLTE Stock Alerts